Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

Tofacitinib, a hair regrowth treatment, may worsen acne.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Baricitinib significantly improves hair regrowth in severe alopecia areata.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

You might not need to stop cancer treatment if you get a rare skin reaction from EGFR inhibitors, as skin treatments can help manage it.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Tofacitinib helped regrow hair in a woman with alopecia areata.

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

CS12192 effectively treats alopecia areata with better safety than current options.

Kidney cancer cells without folliculin are more sensitive to radiation due to increased self-eating cell death.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Sorafenib may cause hand-foot and stump syndrome, requiring early detection and management.

Moles may stop growing due to cell cooperation, not just because of individual cell aging.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Normal cells outcompete and remove mutant cells in the pancreas with the help of the EphA2 receptor.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Aumolertinib effectively controls lung cancer and improves quality of life.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

Mutations in the ACTB gene cause Becker’s nevi and may lead to muscle issues in Becker’s nevus syndrome.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.